LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 76.94 | 17.25 | 963 | 5681 | 0.1695 | 0.6176 | MN20160310_N02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 76.94 | 17.25 | 1094 | 5681 | 0.1926 | 0.6424 | MN20160310_N02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 76.94 | 17.25 | 10 | 5681 | 0.0018 | -0.0631 | MN20160310_N02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 76.94 | 17.25 | 1321 | 5681 | 0.2325 | 0.6799 | MN20160310_N02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 78.91 | 17.25 | 1007 | 5730 | 0.1757 | 0.6251 | MN20160310_N02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 78.91 | 17.25 | 1198 | 5730 | 0.2091 | 0.6591 | MN20160310_N02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 78.91 | 17.25 | 14 | 5730 | 0.0024 | -0.0246 | MN20160310_N02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 78.91 | 17.25 | 1277 | 5730 | 0.2228 | 0.6718 | MN20160310_N02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 80.88 | 17.25 | 1066 | 5826 | 0.1830 | 0.6339 | MN20160310_N02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 80.88 | 17.25 | 1237 | 5826 | 0.2123 | 0.6631 | MN20160310_N02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 80.88 | 17.25 | 11 | 5826 | 0.0019 | -0.0522 | MN20160310_N02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 80.88 | 17.25 | 1362 | 5826 | 0.2338 | 0.6822 | MN20160310_N02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 82.85 | 17.25 | 1037 | 5861 | 0.1769 | 0.6277 | MN20160310_N02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 82.85 | 17.25 | 1247 | 5861 | 0.2127 | 0.6638 | MN20160310_N02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 82.85 | 17.25 | 12 | 5861 | 0.0020 | -0.0423 | MN20160310_N02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 82.85 | 17.25 | 1395 | 5861 | 0.2380 | 0.6861 | MN20160310_N02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 84.82 | 17.25 | 1186 | 5924 | 0.2002 | 0.6524 | MN20160310_N02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 84.82 | 17.25 | 1336 | 5924 | 0.2255 | 0.6759 | MN20160310_N02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 84.82 | 17.25 | 23 | 5924 | 0.0039 | 0.0347 | MN20160310_N02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 84.82 | 17.25 | 1512 | 5924 | 0.2552 | 0.7007 | MN20160310_N02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 86.79 | 17.25 | 1094 | 6008 | 0.1821 | 0.6347 | MN20160310_N02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 86.79 | 17.25 | 1275 | 6008 | 0.2122 | 0.6646 | MN20160310_N02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 86.79 | 17.25 | 1 | 6008 | 0.0002 | -0.2863 | MN20160310_N02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 86.79 | 17.25 | 1543 | 6008 | 0.2568 | 0.7026 | MN20160310_N02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 88.76 | 17.25 | 1222 | 6047 | 0.2021 | 0.6553 | MN20160310_N02 | E08 |